- Home
- MIST vs ORKT Comparison
MIST vs ORKT Comparison
Compare MIST & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- ORKT
- Stock Information
- Founded
- MIST 2003
- ORKT 2003
- Country
- MIST Canada
- ORKT Singapore
- Employees
- MIST N/A
- ORKT N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- ORKT
- Sector
- MIST Health Care
- ORKT
- Exchange
- MIST Nasdaq
- ORKT NYSE
- Market Cap
- MIST 89.8M
- ORKT N/A
- IPO Year
- MIST N/A
- ORKT 2024
- Fundamental
- Price
- MIST $1.94
- ORKT $0.58
- Analyst Decision
- MIST Strong Buy
- ORKT Strong Buy
- Analyst Count
- MIST 2
- ORKT 1
- Target Price
- MIST $7.50
- ORKT $5.00
- AVG Volume (30 Days)
- MIST 566.2K
- ORKT 266.3K
- Earning Date
- MIST 08-07-2025
- ORKT 01-01-0001
- Dividend Yield
- MIST N/A
- ORKT N/A
- EPS Growth
- MIST N/A
- ORKT N/A
- EPS
- MIST N/A
- ORKT N/A
- Revenue
- MIST N/A
- ORKT $2,962,282.00
- Revenue This Year
- MIST N/A
- ORKT $9.63
- Revenue Next Year
- MIST N/A
- ORKT N/A
- P/E Ratio
- MIST N/A
- ORKT N/A
- Revenue Growth
- MIST N/A
- ORKT N/A
- 52 Week Low
- MIST $0.63
- ORKT $0.40
- 52 Week High
- MIST $2.75
- ORKT $8.00
- Technical
- Relative Strength Index (RSI)
- MIST 65.73
- ORKT N/A
- Support Level
- MIST $1.86
- ORKT N/A
- Resistance Level
- MIST $1.97
- ORKT N/A
- Average True Range (ATR)
- MIST 0.10
- ORKT 0.00
- MACD
- MIST 0.00
- ORKT 0.00
- Stochastic Oscillator
- MIST 80.00
- ORKT 0.00
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).